Sensitivity analysis of per-protocol time-to-event treatment efficacy in randomized clinical trials

Journal of the American Statistical Association

Volumn 108, Issue 503, 2013, Pages 789-800

  Gilbert, Peter B ^a   Shepherd, Bryan E ^b   Hudgens, Michael G ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

Author keywords

Causal inference; Exclusion restriction; Ignorance region; Intention to treat; Principal stratification; Selection bias

Indexed keywords

EID: 84890092988     PISSN: 01621459     EISSN: 1537274X     Source Type: Journal    
DOI: 10.1080/01621459.2013.786649     Document Type: Article

References (24)

1. Angrist, J., Imbens, G.W., and Rubin, D. B. (1996), "Identification of Causal Effects Using Instrumental Variables" (with discussion), Journal of the American Statistical Association, 91, 444-472. [791].
2. Baker, S. (1998), "Analysis of Survival Data From a Randomized Trial With All-or-None Compliance: Estimating the Cost-Effectiveness of a Cancer Screening Program, " Journal of the American Statistical Association, 93, 929-934. [791].
3. Chiba, Y. (2012), "The Large Sample Bounds on the Principal Strata Effect With Application to a Prostate Cancer Prevention Trial, " The International Journal of Biostatistics, 8. [793].
4. Cuzick, J., Sasieni, P., Myles, J., and Tyler, J. (2007), "Estimating the Effect of Treatment in a Proportional Hazards Model in the Presence of Non-Compliance and Contamination, " Journal of the Royal Statistical Society, Series B, 69, 565-588. [791].
5. Flynn, N. M., Forthal, D. N., Harro, C. D., Judson, F. N., Mayer, K. H., Para, M. F.; and rgp120 HIV Vaccine Study Group (2005), "Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV Infection, " Journal of Infectious Diseases, 191, 654-665. [798].
6. Follmann, D. A. (2000), "On the Effect of Treatment Among Would-be Treatment Compliers: An Analysis of the Multiple Risk Factor Intervention Trial, " Journal of the American Statistical Association, 95, 1101-1109. [791].
7. Frangakis, C. E., and Rubin, D. B. (2002), "Principal Stratification in Causal Inference, " Biometrics, 58, 22-29. [791,792].
8. Gilbert, P. B., Berger, J. O., Stablein, D., Becker, S., Essex, M., Hammer, S. M., Kim, J., and DeGruttola, V. G. (2011), "Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: A Case Study for Statistical Issues in Efficacy Trials, " Journal of Infectious Diseases, 203, 969-975. [790].
9. Hernán, M.A. (2010), "TheHazard ofHazardRatios, " Epidemiology, 21, 13-15. [791,799].
10. Horne, A. D., Lachenbruch, P. A., and Goldenthal, K. L. (2001), "Intent-to-Treat Analysis and Preventive Vaccine Efficacy, " Vaccine, 19, 319-326. [790].
11. Imbens, G. W., and Manski, C. F. (2004), "Confidence Intervals for Partially Identified Parameters, " Econometrica, 72, 1845-1857. [796].
12. Loeys, T., and Goetghebeur, E. (2003), "Causal Proportional Hazards Estimator for the Effect of Treatment Actually Received in a Randomized Trial With all or Nothing Compliance, " Biometrics, 59, 100-105. [791].
13. Loeys, T., Goetghebeur, E., and Vandebosch, A. (2005), "Causal Proportional Hazards Models and Time-Constant Exposure in Randomized Clinical Trials, " Lifetime Data Analysis, 11, 435-449. [791].
14. Nie, H., Cheng, J., and Small, D. (2011), "Inference for the Effect of Treatment on Survival Probability in Randomized Trials With Noncompliance and Administrative Censoring, " Biometrics, 67, 1397-1405. [791].
15. Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., Benenson, M., Gurunathan, S., Tartaglia, J., McNeil, J. G., Francis, D. P., Stablein, D., Birx, D. L., Chunsuttiwat, S., Khamboonruang, C., Thongcharoen, P., Robb, M. L., Michael, N. L., Kunasol, P., Kim, J. H., and MOPH-TAVEG Investigators. (2009), "VaccinationWith ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand, " New England Journal of Medicine, 361, 2209-2220. [789,796,798].
16. Robins, J. M. (1997), "Non-Response Models for the Analysis of Non-Monotone Non-Ignorable Missing Data, " Statistics in Medicine, 16, 21-37. [792].
17. Rosenbaum, P. R. (1984), "The Consequences of Adjustment for a Concomitant Variable That has been Affected by the Treatment, " The Journal of the Royal Statistical Society, Series A, 147, 656-666. [789].
18. Scharfstein, D. O., Rotnitzky, A., and Robins, J.M. (1999), "Adjusting for Nonignorable Drop-Out Using Semiparametric Nonresponse Models, " Journal of the American Statistical Association, 94, 1096-1146. [792].
19. Shepherd, B. E., Gilbert, P. B., and Dupont, C. T. (2011), "Sensitivity Analyses Comparing Time-to-Event Outcomes Only Existing in a Subset Selected Post-Randomization and Relaxing Monotonicity, " Biometrics, 67, 1100-1110. [791].
20. Shepherd, B. E., Gilbert, P. B., and Lumley, T. (2007), "Sensitivity Analyses Comparing Time-to-Event Outcomes Only Existing in a Subset Selected Post-Randomization, " Journal of the American Statistical Association, 102, 573-582. [791,796].
21. Todem, D., Fine, J., and Peng, L. (2010), "A Global Sensitivity Test for Evaluating Statistical Hypotheses With Nonidentifiable Models, " Biometrics, 66, 558-566. [796].
22. Tsiatis, A. A., Davidian, M., Zhang, M., and Lu, X. (2008), "Covariate Adjustment for Two-Sample Treatment Comparisons in Randomized Clinical Trials: A Principled Yet Flexible Approach, " Statistics in Medicine, 27, 4658-4677. [790].
23. Vansteelandt, S., Goetghebeur, E., Kenward, M. G., andMolenberghs, G. (2006), "Ignorance and Uncertainty Regions as Inferential Tools in a Sensitivity Analysis, " Statistica Sinica, 16, 953-979. [792,795].
24. Zhang, J. L., and Rubin, D. B. (2003), "Estimation of Causal Effects Via Principal StratificationWhen Some Outcomes are Truncated by 'Death,' " Journal of Educational and Behavioral Statistics, 28, 353-368. [793].